Contemporary surgical and non-surgical management of Peyronie's disease

Transl Androl Urol. 2018 Aug;7(4):603-617. doi: 10.21037/tau.2018.04.06.

Abstract

Numerous treatments have been proposed for Peyronie's disease (PD). As the evidence base has expanded, the field of operative and non-operative options for patients has narrowed. Collagenase clostridium hystolyticum (CCH) injection now comprises the medical option, and surgical possibilities entail penile plication, plaque incision/excision and grafting, and prosthesis implantation. Still, questions abound regarding the optimal approach and indication for each of these treatments. We conducted a review of literature exploring the contemporary management of PD with a particular focus on work since the last American Urologic Association's (AUA) guidelines update for PD. Recent results and discussion indicate trends toward minimal invasiveness, toward a more holistic approach to the PD patient, and away from algorithmic management, galvanized, in part, by data challenging long-held beliefs.

Keywords: Peyronie’s disease (PD); collagenase clostridium hystolyticum (CCH); grafting, penile prosthesis; penile plication; plaque excision; plaque incision.

Publication types

  • Review